FDA alerts providers to COVID-19 rapid test recall
The Food and Drug Administration last week announced a Class 1 recall of two COVID-19 tests the agency had not authorized or approved. Due to the potential for false results, FDA said health care providers and testing programs should consider retesting patients with an authorized test if they administered the CovClear COVID-19 Rapid Antigen Test less than two weeks ago and suspect an inaccurate result, or administered the ImmunoPass COVID-19 Neutralizing Antibody Rapid Test and suspect a recent or prior COVID-19 infection.
Related News Articles
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…